The firm said the products would be based on CBD, or Cannabidiol --
a constitute of the cannabis plant that is used in some health
products. Together said it believes that the CBD market is worth
hundreds of millions of dollars.
"CBD has a variety of properties that are beneficial to various
diseases because of it anti-inflammatory, anti-bacterial,
anti-oxidant and anti-aging properties, and its market is expected
to grow 700 percent by the year 2020," it said.

The joint company will be set up in Europe, with Together holding 51
percent and Premier 49 percent. Together will provide up to 2
million euros ($2.3 million)in loan for building the venture's
factory.
[to top of second column] |

Investors have piled into cannabis stocks as many countries consider
legalizing marijuana at least for medicinal purposes.
Shares of Together, which has a market value of nearly 400 million
shekels ($110 million), were down 6.8 percent on Tuesday in Tel Aviv
but have soared nearly 450 percent so far in 2018.
(Reporting by Maayan Lubell; Editing by Steven Scheer)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |